4.6 Article

Patient-initiated follow up affects fear of recurrence and healthcare use: a randomised trial in early-stage endometrial cancer

Journal

Publisher

WILEY
DOI: 10.1111/1471-0528.15396

Keywords

Alarm symptoms; cancer; endometrial carcinoma; gynaecological malignancy; patient-initiated follow up; post-treatment surveillance; recurrence; uterus

Funding

  1. Danish Cancer Society [R94-A5679 Rp7423]
  2. National Research Centre of Cancer Rehabilitation, University of Southern Denmark
  3. Region of Southern Denmark [13/6697]
  4. Odense University Hospital [12/26914]

Ask authors/readers for more resources

Objective Design To test the hypothesis that patient-initiated follow up reduces the fear of cancer recurrence (FCR) and healthcare use when compared with traditional hospital-based follow up. Pragmatic, multicentre randomised trial. Setting Population Four Danish departments of gynaecology between May 2013 and May 2016. One hundred and fifty-six women diagnosed with International Federation of Gynecology and Obstetrics (FIGO) stage I low-intermediate risk endometrial carcinoma. Methods Main outcome measures Women allocated to the control group attended hospital-based follow up consisting of regular outpatient visits for 3 years after primary treatment. Women in the intervention group were instructed in patient-initiated follow up, which included careful instruction in alarm symptoms and options for self-referral rather than a schedule of examinations. The primary end point was FCR as measured by the Fear of Cancer Recurrence Inventory (FCRI) after 10 months of follow up. Secondary end points included cancer-related use of primary and secondary health care during the first 10 months after treatment. Results Conclusions In the primary analysis, FCR decreased significantly more in the control group from baseline to 10 months of follow up (difference -5.9, 95% CI -10.9 to -0.9). The majority of this improvement happened after only 3 months of follow up. Women receiving the intervention had fewer examinations at the department compared with the control group (0 versus 2 median visits, P < 0.01) and 58% of these examinations were scheduled because of vaginal bleeding. Hospital-based follow up alleviates FCR significantly more than patient-initiated follow up, though the estimated difference was small. Patient-initiated follow up is a feasible, potentially cost-reducing follow-up approach in a population of endometrial cancer survivors with low risk of recurrence. The decision to use patient-initiated follow up should balance these benefits and harms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

SENTIREC - The sentinel node mapping in women with cervical cancer study - Patient-reported early lymphedema and its impact on quality of life

Sara Elisabeth Sponholtz, Nicole P. M. Ezendam, Belle H. de Rooij, Erik Parner, Ole Mogensen, Malene Grubbe Hildebrandt, Doris Schledermann, Algirdas Markauskas, Ligita Paskeviciute Froding, Katrine Fuglsang, Sarah Marie Bjornholt, Pernille Tine Jensen

Summary: This study evaluates the occurrence and severity of early lymphedema, as well as its impact on quality of life, in women undergoing surgery for early-stage cervical cancer. The results show that sentinel lymph node (SLN) mapping alone carries a low risk of lymphedema, while completion pelvic lymphadenectomy (PL) is associated with a high incidence of early lymphedema. Reporting lymphedema is significantly associated with impairment in various aspects of physical, psychological, and social functioning.

GYNECOLOGIC ONCOLOGY (2022)

Review Obstetrics & Gynecology

Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis

Dina Overgaard Eriksen, Pernille Tine Jensen, Jeppe Bennekou Schroll, Anne Hammer

Summary: This review and meta-analysis aimed to investigate the association between human papilloma virus (HPV) vaccination administered after excisional treatment of cervical intraepithelial neoplasia (CIN) and the risk of CIN grade 2 or worse (CIN2+) recurrence. The analysis included nine studies and found that post-treatment HPV vaccination was associated with a significantly reduced risk of CIN2+ recurrence. However, there were serious risks of bias in the included studies.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)

Article Psychology, Multidisciplinary

Sexual Activity in Couples Dealing With Breast Cancer. A Cohort Study of Associations With Patient, Partner and Relationship-Related Factors

Nina Rottmann, Pia Veldt Larsen, Christoffer Johansen, Mariet Hagedoorn, Susanne Oksbjerg Dalton, Dorte Gilsa Hansen

Summary: Breast cancer has a profound impact on the sex life of couples. Patient-, partner-, and relationship-related characteristics are associated with sexual activity after breast cancer diagnosis. Couples with higher emotional closeness, affectionate behavior, and satisfaction with dyadic coping are more likely to engage in sexual activity.

FRONTIERS IN PSYCHOLOGY (2022)

Article Oncology

Use of hypnotics among women diagnosed with cervical cancer-A population-based cohort study

Trine Allerslev Horsbol, Susanne K. Kjaer, Elisabeth Wreford Andersen, Gunn Ammitzboll, Lau Caspar Thygesen, Christoffer Johansen, Pernille Tine Jensen, Ligita Paskeviciute Froding, Henrik Lajer, Susanne Oksbjerg Dalton

Summary: This nationwide register-based cohort study found that women diagnosed with cervical cancer have an increased risk of using hypnotics, especially during the first year after diagnosis. Higher age, lower education, previous use of antidepressants or anxiolytics, and advanced disease were identified as risk factors for prolonged use of hypnotics.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Improved stratification of stage-specific survival for cervical uterine cancer by integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO classification

Jorun Holm, Oke Gerke, Mie Holm Vilstrup, Diana Spasojevic, Sara Elisabeth Sponholtz, Kirsten Marie Jochumsen, Anders Thomassen, Malene Grubbe Hildebrandt, Pernille Tine Jensen

Summary: This study aimed to investigate the prognostic value of lymph node metastases identified by imaging in patients with carcinoma of the uterine cervix (CCU). The results showed that approximately one-third of CCU patients staged according to FIGO-2009 had suspected lymph node metastasis on imaging and were upstaged to stage IIIC according to FIGO-2018. The cancer-specific mortality was significantly lower in lymph node-negative patients in stages IBI-II, supporting the stage migration due to suspected lymph node metastasis within this group.

GYNECOLOGIC ONCOLOGY (2022)

Article Oncology

Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe

W. L. Van der Kolk, A. G. J. Van der Zee, B. M. Slomovitz, P. J. W. Baldwin, H. C. Van Doorn, J. A. De Hullu, J. Van der Velden, K. N. Gaarenstroom, B. F. M. Slangen, P. Kjolhede, M. Brannstrom, I Vergote, C. M. Holland, R. Coleman, E. B. L. Van Dorst, W. J. Van Driel, D. Nunns, M. Widschwendter, D. Nugent, P. A. DiSilvestro, R. S. Mannel, M. Y. Tjiong, D. Boll, D. Cibula, A. Covens, D. Provencher, I. B. Runnebaum, B. J. Monk, V Zanagnolo, K. Tamussino, M. H. M. Oonk, C. F. Levenback, R. H. Hermans, J. Bouda, A. Sharma, D. Luesley, P. Ellis, D. J. Cruickshank, T. J. Duncan, K. Kieser, C. Palle, N. M. Spirtos, D. M. O'Malley, M. M. Leitao, M. Geller, K. Dhar, V Asher, D. H. Tobias, C. Borgfeldt, J. S. Lea, M. Lood, J. Bailey, B. Eyjolfsdottir, S. Attard-Montalto, K. S. Tewari, P. Persson, R. Manchanda, P. Jensen, L. Van Le

Summary: This study analyzed patients with early-stage vulvar squamous cell carcinoma and a metastatic unilateral inguinal sentinel lymph node to determine whether treatment of the contralateral groin can be safely omitted.

GYNECOLOGIC ONCOLOGY (2022)

Article Multidisciplinary Sciences

SDM:HOSP- a generic model for hospital-based implementation of shared decision making

Karina Dahl Steffensen, Dorte Gilsa Hansen, Kurt Espersen, Susanne Lauth, Peter Fosgrau, Anders Meinert Pedersen, Peter Sigerseth Groen, Christian Sauvr, Karina Olling

Summary: This paper describes the development of a model called SDM:HOSP, which aims to achieve lasting shared decision making (SDM) between patients and healthcare professionals. Through four phases of development, including the development of conceptual elements, field testing, evaluation, and the development of the final model, SDM:HOSP can be easily adapted to different organizations and cultures.

PLOS ONE (2023)

Article Medicine, Research & Experimental

A NEw MOdel of individualized and patient-centered follow-up for women with gynecological cancer (the NEMO study)-protocol and rationale of a randomized clinical trial

Stinne Holm Bergholdt, Dorte Gilsaa Hansen, Anna Thit Johnsen, Bo Snedker Boman, Pernille Tine Jensen

Summary: This study aims to test a nurse-led, individualized, and need-based intervention with a specific focus on patient empowerment against a standard physician-led model primarily focusing on the detection of recurrence. The study will provide new information about follow-up in early-stage gynecological cancer settings and contribute to the improvement of future follow-up programs.

TRIALS (2023)

Article Oncology

Cancer worry is associated with increased use of supportive health care-results from the multinational InCHARGE study

M. M. Jeppesen, S. H. Bergholdt, A. G. Bentzen, B. H. de Rooij, M. Skorstad, N. P. M. Ezendam, L. V. van de Poll-Franse, I. Vistad, P. T. Jensen

Summary: This study assessed healthcare utilization among female cancer survivors with endometrial, cervical, and ovarian cancer in the Netherlands, Norway, and Denmark. It found that cancer worry was associated with increased use of supportive care services.

JOURNAL OF CANCER SURVIVORSHIP (2023)

Article Obstetrics & Gynecology

Patient-initiated follow-up in women with early-stage endometrial cancer: a long-term follow-up of the OPAL trial

M. C. Rulanda, O. Mogensen, P. T. Jensen, D. G. Hansen, C. Wu, M. M. Jeppesen

Summary: This study compares the effects of patient initiated follow up (PIFU) versus hospital based follow up (HBFU) on fear of cancer recurrence (FCR), quality of life (QoL), and healthcare use after 34 months of follow up. The results indicate that patient initiated follow up is a valid alternative to hospital based follow up for low-intermediate risk endometrial carcinoma patients.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2023)

Article Oncology

A federated approach to identify women with early-stage cervical cancer at low risk of lymph node metastases

Hans H. B. Wenzel, Anna N. Hardie, Arturo Moncada-Torres, Claus K. Hogdall, Ruud L. M. Bekkers, Henrik Falconer, Pernille T. Jensen, Hans W. Nijman, Maaike A. van der Aa, Frank Martin, Anna J. van Gestel, Valery E. P. P. Lemmens, Pernilla Dahm-Kahler, Emilia Alfonzo, Jan Persson, Linnea Ekdahl, Sahar Salehi, Ligita P. Froding, Algirdas Markauskas, Katrine Fuglsang, Tine H. Schnack

Summary: By utilizing federated learning, researchers have developed a tool to identify a low-risk group of patients with presumed early-stage cervical cancer for lymph node dissection decision-making.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

The SENTIREC-endo study-Risks and benefits of a national adoption of sentinel node mapping in low and intermediate risk endometrial cancer

Sarah Marie Bjornholt, Sarah Elizabeth Sponholtz, Ole Mogensen, Kirsten Bouchelouche, Erik Thorlund Parner, Gudrun Neumann, Kirsten Marie Jochumsen, Bushra Hassan Hamid, Morten Billow Davidsen, Signe Frahm Bjorn, Katja Dahl, Pernille Tine Jensen

Summary: The SENTIREC-endo study investigates the risks and benefits of a national protocolled adoption of sentinel lymph node mapping in women with early-stage low-grade endometrial cancer. The study found that this technique is safe and can provide more accurate treatment allocation for patients in both low and intermediate risk groups.

GYNECOLOGIC ONCOLOGY (2023)

Article Health Care Sciences & Services

A multi-method approach to selecting PRO-CTCAE symptoms for patient-reported outcome in women with endometrial or ovarian cancer undergoing chemotherapy

Mille Guldager Christiansen, Helle Pappot, Pernille Tine Jensen, Mansoor Raza Mirza, Mary Jarden, Karin Piil

Summary: The objective of this study was to identify items appropriate for use in a PRO tool for women with endometrial or ovarian cancer undergoing treatment with taxanes in combination with carboplatin. A comprehensive literature search, patient advisory board discussions, and expert panel consultations were used to select 21 clinically relevant symptoms from the PRO-CTCAE library.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2023)

No Data Available